Patients in Group @ ( @ patients ) received @mg of CC daily for @days starting on day @ of menses , and patients in Group @ ( @ patients ) received @mg of CC daily for @days starting the next day after finishing medroxyprogesterone acetate ( MPA ) ( before withdrawal bleeding ) .